Valuation
Medical EquipmentLive · Yahoo FinancePrice
$82.01
52-Week Range
Decision Context
Scores are balanced across the six engines. No single dimension dominates — this is consistent with a stable, mid-tier quality business.
Based on filing period ending Apr 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
Fed Funds Rate
3.63%
Accommodative
10-Year Treasury
4.48%
2026-05-01
Unemployment
4.3%
Near full employment
CPI Index
334.0
2026-05-01
M2 Money Supply
$23.1T
2026-05-01
The Federal Funds rate stands at 3.63% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 4.48%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.3%; Industrial production index is at 102.6; M2 money supply is $23.1T; CPI index stands at 334.0.
SWOT Analysis — MDT
Inflationary BoomStrengths
Revenue: $36.4B (+8.4% YoY) — Revenue grew 8% — the company sold more goods or services than the prior year.
Weaknesses
Gross Profit: $3.7B (-29.7% YoY) — Gross profit declined 30% — costs are growing faster than revenue.
Gross margin narrowed by 5.6pp — worth monitoring for further cost pressure.
Opportunities
Operating Cash Flow: $7.3B (+4.1% YoY) — Operating cash flow grew 4% — the business generated more cash from day-to-day operations.
EPS (Diluted): $3.73 (+3.3% YoY) — Earnings per share rose 3% — each share earned more.
Net Income: $4.8B (+3.0% YoY) — Profit grew 3% — the company kept more of each dollar earned.
Threats
No significant threats flagged.
Financial Charts
Quarter-over-Quarter Comparison
2026-01-23 → 2026-04-24| Metric | 2026-01-23 | 2026-04-24 | Change |
|---|---|---|---|
| Revenue | $33.5B | $36.4B | ▲8.4% |
| Gross Profit | $3.7B | $3.7B | –0.0% |
| Operating Income | $6.0B | $6.5B | ▲8.6% |
| Net Income | $4.7B | $4.8B | ▲3.0% |
| EPS (diluted) | $3.61 | $3.73 | ▲3.3% |
| Operating CF | $7.0B | $7.3B | ▲4.1% |
Risk factor changes vs prior filing
Gross margin narrowed by 5.6pp — worth monitoring for further cost pressure.
Gross margin narrowed by 5.3pp — worth monitoring for further cost pressure.
Year-over-Year Changes
Gross Profit
$3.7B
was $5.3B
Gross profit declined 30% — costs are growing faster than revenue.
Revenue
$36.4B
was $33.5B
Revenue grew 8% — the company sold more goods or services than the prior year.
Operating Cash Flow
$7.3B
was $7.0B
Operating cash flow grew 4% — the business generated more cash from day-to-day operations.
EPS (Diluted)
$3.73
was $3.61
Earnings per share rose 3% — each share earned more.
Net Income
$4.8B
was $4.7B
Profit grew 3% — the company kept more of each dollar earned.
Risk Flags
0 high · 0 medium · 1 low- ○ Low
Gross margin narrowed by 5.6pp — worth monitoring for further cost pressure.
Price History
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubFiling History — MDT
Get the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade MDT
Links open broker research pages. Not an endorsement or recommendation.
Research Medtronic plc
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.